<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Inflammatory myofibroblastic tumours represent a rare group of lesions reported in various organs but with an unclear aetiology. Although so far they are considered benign, some cases of recurrence and invasive behaviour have been noted. We report three consecutive cases of tumours of the lung, with heterogeneous clinical presentation. They were all treated by means of surgery, with good long-term results. Diagnosing an inflammatory myofibroblastic tumour relies mainly on an experienced pathologist.</p></abstract>

Inflammatory myofibroblastic tumours represent a rare group of lesions reported in various organs but with an unclear aetiology. Although so far they are considered benign, some cases of recurrence and invasive behaviour have been noted. We report three consecutive cases of tumours of the lung, with heterogeneous clinical presentation. They were all treated by means of surgery, with good long-term results. Diagnosing an inflammatory myofibroblastic tumour relies mainly on an experienced pathologist.

Inflammatory myofibroblastic tumours of the lung: a case series

Pneumologia

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Tumori miofibroblastice inflamatorii ale plămânului: serie de cazuri

Inflammatory myofibroblastic tumours represent a rare group of lesions reported in various organs but with an unclear aetiology. Although so far they are...

Inflammatory myofibroblastic tumours of the lung: a case series

Article Category: Clinical Cases

Published Online: Oct 11, 2019

Page range: 82 - 86

DOI: https://doi.org/10.2478/pneum-2019-0006

Keywords
inflammatory myofibroblastic tumour, plasma cell granuloma, fibroxanthoma

© 2019 Melinte et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Inflammatory myofibroblastic tumours of the lung: a case series

Article Category: Clinical Cases

Published Online: Oct 11, 2019

Page range: 82 - 86

DOI: https://doi.org/10.2478/pneum-2019-0006

Keywordsinflammatory myofibroblastic tumour, plasma cell granuloma, fibroxanthoma

© 2019 Melinte et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Keywords
inflammatory myofibroblastic tumour, plasma cell granuloma, fibroxanthoma